Role of surgical therapy in the management of gestational trophoblastic neoplasia Obstetrics & Gynecology Science 58/4 :277-283,2015
Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim’s technique and comparison to laparotomy Obstetrics & Gynecology Science 60/2 :178-186,2017
External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma JOURNAL OF GYNECOLOGIC ONCOLOGY 28/6 :e73-,2017
Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models. CANCER RESEARCH AND TREATMENT 50/3 :956-963,2018
Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center JOURNAL OF GYNECOLOGIC ONCOLOGY 29/4 :e63-e73,2018
Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY 25/5 :823-831,2018
Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy. PLOS ONE 13/9 :203,366-203,376,2018
Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer GYNECOLOGIC ONCOLOGY 148/1 :62-67,2018
In-bag power morcellation technique in single-port laparoscopic myomectomy Obstetrics & Gynecology Science 61/2 :267-273,2018
Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer Obstetrics & Gynecology Science 61/2 :227-234,2018
Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience YONSEI MEDICAL JOURNAL 59/8 :930-936,2018
Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced?stage ovarian cancer CANCER MEDICINE 8/2 :564-571,2019
Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy EJSO 45/4 :644-649,2019
Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708) BMC CANCER 19/1 :e341-,2019